|
Anti HLA-DR (MHC II)
|
FITC
|
Becton Dickinson, Franklin Lakes, NJ, USA
|
L243
|
|
Anti-h/m/rNG2/MCSP
|
PE
|
R&D Systems, McKinley Place, MN, USA
|
LHM-2
|
|
CD105
|
APC
|
Caltag Laboratories, Carlsbad, CA, USA
|
SN6
|
|
CD14
|
PE-Cy7
|
Becton Dickinson
|
MdeltaP9
|
|
CD140b
|
PE
|
Becton Dickinson
|
28D4
|
|
CD144 (VE-Cadherin)
|
APC
|
BioLegend, San Diego, CA, USA
|
BV9
|
|
CD19
|
FITC
|
Becton Dickinson
|
SJ25C1
|
|
CD271
|
PE
|
Becton Dickinson
|
C40-1457
|
|
CD31
|
FITC
|
Becton Dickinson
|
WM59
|
|
CD34
|
PE
|
Becton Dickinson
|
8G12
|
|
CD45
|
APC
|
Becton Dickinson
|
HI30
|
|
CD73
|
PE
|
Becton Dickinson
|
AD2
|
|
CD90
|
FITC
|
Immunotech, Quebec, Canada
|
F15-42-1-5
|
|
Mouse IgG1
|
FITC
|
Becton Dickinson
|
X40
|
|
Mouse IgG1
|
PE
|
Becton Dickinson
|
X40
|
|
Mouse IgG1
|
APC
|
Becton Dickinson
|
X40
|
|
Mouse IgG2a
|
PE
|
Becton Dickinson
|
X39
|
